-
Je něco špatně v tomto záznamu ?
Metallacarborane Sulfamides: Unconventional, Specific, and Highly Selective Inhibitors of Carbonic Anhydrase IX
B. Grüner, J. Brynda, V. Das, V. Šícha, J. Štěpánková, J. Nekvinda, J. Holub, K. Pospíšilová, M. Fábry, P. Pachl, V. Král, M. Kugler, V. Mašek, M. Medvedíková, S. Matějková, A. Nová, B. Lišková, S. Gurská, P. Džubák, M. Hajdúch, P. Řezáčová,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- amidy chemie MeSH
- biologický transport účinky léků MeSH
- borany chemie farmakologie MeSH
- doxorubicin metabolismus MeSH
- inhibitory karboanhydras chemie farmakologie MeSH
- karboanhydrasa IX chemie metabolismus MeSH
- katalytická doména MeSH
- lidé MeSH
- molekulární modely MeSH
- myši MeSH
- nádorové buněčné linie MeSH
- racionální návrh léčiv MeSH
- synergismus léků MeSH
- xenogenní modely - testy antitumorózní aktivity MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Carbonic anhydrase IX (CAIX) is a transmembrane enzyme that regulates pH in hypoxic tumors and promotes tumor cell survival. Its expression is associated with the occurrence of metastases and poor prognosis. Here, we present nine derivatives of the cobalt bis(dicarbollide)(1-) anion substituted at the boron or carbon sites by alkysulfamide group(s) as highly specific and selective inhibitors of CAIX. Interactions of these compounds with the active site of CAIX were explored on the atomic level using protein crystallography. Two selected derivatives display subnanomolar or picomolar inhibition constants and high selectivity for the tumor-specific CAIX over cytosolic isoform CAII. Both derivatives had a time-dependent effect on the growth of multicellular spheroids of HT-29 and HCT116 colorectal cancer cells, facilitated penetration and/or accumulation of doxorubicin into spheroids, and displayed low toxicity and showed promising pharmacokinetics and a significant inhibitory effect on tumor growth in syngenic breast 4T1 and colorectal HT-29 cancer xenotransplants.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023488
- 003
- CZ-PrNML
- 005
- 20211209132243.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jmedchem.9b00945 $2 doi
- 035 __
- $a (PubMed)31568723
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Grüner, Bohumír $u Institute of Inorganic Chemistry of the Czech Academy of Sciences , 250 68 Řež , Czech Republic.
- 245 10
- $a Metallacarborane Sulfamides: Unconventional, Specific, and Highly Selective Inhibitors of Carbonic Anhydrase IX / $c B. Grüner, J. Brynda, V. Das, V. Šícha, J. Štěpánková, J. Nekvinda, J. Holub, K. Pospíšilová, M. Fábry, P. Pachl, V. Král, M. Kugler, V. Mašek, M. Medvedíková, S. Matějková, A. Nová, B. Lišková, S. Gurská, P. Džubák, M. Hajdúch, P. Řezáčová,
- 520 9_
- $a Carbonic anhydrase IX (CAIX) is a transmembrane enzyme that regulates pH in hypoxic tumors and promotes tumor cell survival. Its expression is associated with the occurrence of metastases and poor prognosis. Here, we present nine derivatives of the cobalt bis(dicarbollide)(1-) anion substituted at the boron or carbon sites by alkysulfamide group(s) as highly specific and selective inhibitors of CAIX. Interactions of these compounds with the active site of CAIX were explored on the atomic level using protein crystallography. Two selected derivatives display subnanomolar or picomolar inhibition constants and high selectivity for the tumor-specific CAIX over cytosolic isoform CAII. Both derivatives had a time-dependent effect on the growth of multicellular spheroids of HT-29 and HCT116 colorectal cancer cells, facilitated penetration and/or accumulation of doxorubicin into spheroids, and displayed low toxicity and showed promising pharmacokinetics and a significant inhibitory effect on tumor growth in syngenic breast 4T1 and colorectal HT-29 cancer xenotransplants.
- 650 _2
- $a amidy $x chemie $7 D000577
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologický transport $x účinky léků $7 D001692
- 650 _2
- $a borany $x chemie $x farmakologie $7 D001880
- 650 _2
- $a karboanhydrasa IX $x chemie $x metabolismus $7 D000071231
- 650 _2
- $a inhibitory karboanhydras $x chemie $x farmakologie $7 D002257
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a doxorubicin $x metabolismus $7 D004317
- 650 _2
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a synergismus léků $7 D004357
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a xenogenní modely - testy antitumorózní aktivity $7 D023041
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Brynda, Jiří $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nám. 2 , 16610 Prague , Czech Republic. Institute of Molecular Genetics of the Czech Academy of Sciences , Flemingovo nam. 2 , 16610 Prague , Czech Republic.
- 700 1_
- $a Das, Viswanath $u Institute of Molecular and Translational Medicine , Olomouc, Hněvotínská 1333/5 , 77900 Olomouc , Czech Republic. Cancer Research Czech Republic , Hněvotínská 5 , 77900 Olomouc , Czech Republic.
- 700 1_
- $a Šícha, Václav $u Institute of Inorganic Chemistry of the Czech Academy of Sciences , 250 68 Řež , Czech Republic.
- 700 1_
- $a Štěpánková, Jana $u Institute of Molecular and Translational Medicine , Olomouc, Hněvotínská 1333/5 , 77900 Olomouc , Czech Republic. Cancer Research Czech Republic , Hněvotínská 5 , 77900 Olomouc , Czech Republic.
- 700 1_
- $a Nekvinda, Jan $u Institute of Inorganic Chemistry of the Czech Academy of Sciences , 250 68 Řež , Czech Republic. Department of Organic Chemistry, Faculty of Natural Science , Charles University , Hlavova 2030 , 12800 Prague 2, Czech Republic.
- 700 1_
- $a Holub, Josef $u Institute of Inorganic Chemistry of the Czech Academy of Sciences , 250 68 Řež , Czech Republic.
- 700 1_
- $a Pospíšilová, Klára $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nám. 2 , 16610 Prague , Czech Republic.
- 700 1_
- $a Fábry, Milan $u Institute of Molecular Genetics of the Czech Academy of Sciences , Flemingovo nam. 2 , 16610 Prague , Czech Republic.
- 700 1_
- $a Pachl, Petr $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nám. 2 , 16610 Prague , Czech Republic.
- 700 1_
- $a Král, Vlastimil $u Institute of Molecular Genetics of the Czech Academy of Sciences , Flemingovo nam. 2 , 16610 Prague , Czech Republic.
- 700 1_
- $a Kugler, Michael $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nám. 2 , 16610 Prague , Czech Republic.
- 700 1_
- $a Mašek, Vlastimil $u Institute of Molecular and Translational Medicine , Olomouc, Hněvotínská 1333/5 , 77900 Olomouc , Czech Republic.
- 700 1_
- $a Medvedíková, Martina $u Institute of Molecular and Translational Medicine , Olomouc, Hněvotínská 1333/5 , 77900 Olomouc , Czech Republic.
- 700 1_
- $a Matějková, Stanislava $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nám. 2 , 16610 Prague , Czech Republic.
- 700 1_
- $a Nová, Alice $u Institute of Molecular and Translational Medicine , Olomouc, Hněvotínská 1333/5 , 77900 Olomouc , Czech Republic.
- 700 1_
- $a Lišková, Barbora $u Institute of Molecular and Translational Medicine , Olomouc, Hněvotínská 1333/5 , 77900 Olomouc , Czech Republic. $7 xx0267204
- 700 1_
- $a Gurská, Soňa $u Institute of Molecular and Translational Medicine , Olomouc, Hněvotínská 1333/5 , 77900 Olomouc , Czech Republic. $7 xx0267298
- 700 1_
- $a Džubák, Petr $u Institute of Molecular and Translational Medicine , Olomouc, Hněvotínská 1333/5 , 77900 Olomouc , Czech Republic. Cancer Research Czech Republic , Hněvotínská 5 , 77900 Olomouc , Czech Republic.
- 700 1_
- $a Hajdúch, Marián $u Institute of Molecular and Translational Medicine , Olomouc, Hněvotínská 1333/5 , 77900 Olomouc , Czech Republic. Cancer Research Czech Republic , Hněvotínská 5 , 77900 Olomouc , Czech Republic.
- 700 1_
- $a Řezáčová, Pavlína $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo nám. 2 , 16610 Prague , Czech Republic. Institute of Molecular Genetics of the Czech Academy of Sciences , Flemingovo nam. 2 , 16610 Prague , Czech Republic.
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 62, č. 21 (2019), s. 9560-9575
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31568723 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20211209132242 $b ABA008
- 999 __
- $a ok $b bmc $g 1595807 $s 1114164
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 62 $c 21 $d 9560-9575 $e 20191016 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20201125